Cx Institutional Abbott Laboratories Transaction History

Cx Institutional

$2.24 Billion
Q3 2024

A detailed history of Cx Institutional transactions in Abbott Laboratories stock. As of the latest transaction made, Cx Institutional holds 12,453 shares of ABT stock, worth $1.46 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

12,453

Previous 12,881 3.32%

Holding current value

$1.46 Million

Previous $1.34 Million 6.05%

% of portfolio

0.06%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$100.07 - $118.13 $42,829 - $50,559	-428 Reduced 3.32%	12,453 $1.42 Million
Q2 2024 Jul 11, 2024	BUY	$100.73 - $112.44 $39,989 - $44,638	397 Added 3.18%	12,881 $1.34 Million
Q1 2024 Apr 15, 2024	BUY	$109.52 - $120.96 $210,278 - $232,243	1,920 Added 18.17%	12,484 $1.42 Million
Q4 2023 Jan 12, 2024	SELL	$90.19 - $110.4 $992,631 - $1.22 Million	-11,006 Reduced 51.02%	10,564 $1.16 Million
Q3 2023 Oct 17, 2023	SELL	$95.53 - $114.62 $3.68 Million - $4.42 Million	-38,551 Reduced 64.12%	21,570 $2.09 Million
Q2 2023 Jul 26, 2023	BUY	$100.78 - $112.29 $283,998 - $316,433	2,818 Added 4.92%	60,121 $6.55 Million
Q1 2023 May 04, 2023	BUY	$96.86 - $114.01 $817,982 - $962,814	8,445 Added 17.28%	57,303 $5.8 Million
Q4 2022 Feb 03, 2023	BUY	$95.06 - $111.52 $1.54 Million - $1.81 Million	16,222 Added 49.71%	48,858 $5.37 Million
Q3 2022 Nov 04, 2022	BUY	$96.76 - $112.03 $2.12 Million - $2.45 Million	21,894 Added 203.82%	32,636 $3.16 Million
Q2 2022 Aug 02, 2022	SELL	$102.07 - $123.37 $86,657 - $104,741	-849 Reduced 7.32%	10,742 $1.17 Million
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $89,049 - $108,590	781 Added 7.22%	11,591 $1.37 Million
Q4 2021 Jan 18, 2022	BUY	$115.53 - $141.46 $7,393 - $9,053	64 Added 0.6%	10,810 $1.52 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $93,094 - $102,989	798 Added 8.02%	10,746 $1.27 Million
Q2 2021 Aug 04, 2021	BUY	$105.79 - $124.53 $3,279 - $3,860	31 Added 0.31%	9,948 $1.15 Million
Q1 2021 Apr 15, 2021	SELL	$108.84 - $128.23 $7,618 - $8,976	-70 Reduced 0.7%	9,917 $1.19 Million
Q4 2020 Jan 12, 2021	BUY	$105.0 - $114.42 $1,365 - $1,487	13 Added 0.13%	9,987 $1.09 Million
Q3 2020 Oct 13, 2020	BUY	$91.64 - $111.29 $104,011 - $126,314	1,135 Added 12.84%	9,974 $1.09 Million
Q2 2020 Aug 06, 2020	SELL	$76.57 - $98.0 $289,128 - $370,048	-3,776 Reduced 29.93%	8,839 $808,000
Q1 2020 Apr 29, 2020	BUY	$62.82 - $91.86 $249,206 - $364,408	3,967 Added 45.87%	12,615 $995,000
Q3 2019 Oct 10, 2019	SELL	$81.84 - $88.74 $10,557 - $11,447	-129 Reduced 1.47%	8,648 $724,000
Q2 2019 Jul 17, 2019	BUY	$72.88 - $85.0 $9,911 - $11,560	136 Added 1.57%	8,777 $738,000
Q1 2019 Apr 03, 2019	BUY	$66.22 - $80.06 $35,758 - $43,232	540 Added 6.67%	8,641 $691,000
Q4 2018 Jan 14, 2019	BUY	$65.56 - $74.27 $484,160 - $548,483	7,385 Added 1031.42%	8,101 $586,000
Q2 2018 Jul 12, 2018	BUY	$57.57 - $63.54 $21,300 - $23,509	370 Added 106.94%	716 $44,000
Q2 2018 Jul 12, 2018	BUY	$57.57 - $63.54 $19,919 - $21,984	346 New	346 $21,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.

Account

Cx Institutional Abbott Laboratories Transaction History